AI Science Tracker
EN

Systems toxicology unravels multi-tiered carcinogenic networks of zearalenone in gastric cancer.

Affiliation not stated in the reviewed material · 31 Mar 2026 · biology

Discovery

Systems toxicology unravels multi-tiered carcinogenic networks of zearalenone in gastric cancer.

Source check: Source checked. Not independent scientific confirmation.

Finding: An integrated toxicology analysis identified 157 shared zearalenone and gastric-cancer targets; eleven machine-learning algorithms selected six candidate genes. Docking and molecular-dynamics analyses were followed by gastric-cancer cell assays, which supported altered proliferation and migration in vitro. These data do not establish carcinogenicity in humans or in-vivo causal effects.

Technology: Eleven machine-learning algorithms screened shared disease and chemical-target genes to select six candidate driver genes; computational pathway and binding analyses were followed by in-vitro cell experiments.

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
Eleven machine-learning algorithms screened shared disease and chemical-target genes to select six candidate driver genes; computational pathway and binding analyses were followed by in-vitro cell experiments.
Test and result
The primary abstract and Results report 157 common zearalenone and gastric-cancer targets, six machine-learning-selected genes with reported AUC above 0.85, docking and 100-ns molecular-dynamics analyses, and in-vitro MKN-45 cell assays showing increased proliferation and migration at the tested low-concentration conditions. The experimental evidence is cellular and in vitro.
Limitation / still unknown
The cell assays are in-vitro evidence only; human gastric carcinogenicity and in-vivo causal effects were not established.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2026.1762191/full

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse biology discoveries.